About Propound Pharma Consulting Private Limited
Data last updated:
Propound Pharma Consulting Private Limited is a private limited company based in Bangalore, Karnataka, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the business and IT consulting segment of the business process outsourcing sector. It was incorporated on 29 June 2015.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24230KA2015PTC081212. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Poornima Mokshagundam and Prathima Sundhar.
Its last annual general meeting (AGM) was held on 08 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 167 4th Main Road Judicial Layoutthalaghattapura, Bangalore, Karnataka, India – 560062.
As per the financials filed for FY 2025, the company reported a revenue of ₹12,480, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹3.53 Lakh and EBITDA of -₹3.53 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 80% over three years and 23% over five years.
The company is associated with 1 brand: Propound Pharma.
The last known website on record is propoundpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressNo 167 4th Main Road Judicial Layoutthalaghattapura, Bangalore, Karnataka, India – 560062
- IndustryBusiness Outsourcing, Business & IT Consulting
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Associated Brands with Propound Pharma Consulting Private Limited
Propound Pharma Consulting operates one associated brand: Propound Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Consulting services for pharmaceutical and biotech facility design, operations assessment, and regulatory compliance. | propoundpharma.com |
Financials of Propound Pharma Consulting Private Limited FY 2025 filings available
Propound Pharma Consulting Private Limited reported revenue of ₹12,480 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Propound Pharma Consulting Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 23% over five years. EBITDA fell 184% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Propound Pharma Consulting Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹3.53 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.53 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Propound Pharma Consulting Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Propound Pharma Consulting are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Propound Pharma Consulting Private Limited
Propound Pharma Consulting has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poornima Mokshagundam | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
| Prathima Sundhar | Director | 29 Jun 2015 | 11 Years 3 Months | Current |
Peer Comparison of Propound Pharma Consulting Private Limited
Propound Pharma Consulting Private Limited is compared with the companies closest to it by revenue in the Outsourcing industry (Consulting Services). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivkrishna Dealtrade Private Limited | ₹12,500 (FY 2021) | •••• | •••• | -7.0% | •••• | Kolkata, West Bengal, India |
| Maicss Consultancy Private Limited | ₹12,500 (FY 2023) | •••• | •••• | •••• | New Delhi, Delhi, India | |
| Parthsarthi Dealtrade Private Limited | ₹12,500 (FY 2021) | •••• | •••• | 14.0% | •••• | Kolkata, West Bengal, India |
| Arbasia Business Alliance Private Limited | ₹12,500 (FY 2025) | •••• | •••• | •••• | Delhi, India | |
| S S Business Consulting Services Private Limited | ₹12,488 (FY 2025) | •••• | •••• | -88.0% | •••• | Delhi, India |
| Propound Pharma Consulting Private Limited this company | ₹12,480 (FY 2025) | •••• | •••• | -100.0% | •••• | Bangalore, Karnataka, India |
| India Growth Partners Private Limited | ₹12,454 (FY 2024) | •••• | •••• | -99.0% | •••• | Mumbai, Maharashtra, India |
| Ramjay Impex Private Limited | ₹12,436 (FY 2024) | •••• | •••• | -84.0% | •••• | Bangalore, Karnataka, India |
| Altoo Research Private Limited | ₹12,436 (FY 2021) | •••• | •••• | -98.0% | •••• | Gurugram, Haryana, India |
| Eclend Fintech Private Limited | ₹12,434 (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Prime Broking and Trading (OPC) Private Limited | ₹12,390 (FY 2022) | •••• | •••• | 176.0% | •••• | Lucknow, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Propound Pharma Consulting by revenue in the Outsourcing industry (Consulting Services), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Propound Pharma Consulting Private Limited
Propound Pharma Consulting Private Limited is audited by SESHADRI & RANGA RAO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SESHADRI & RANGA RAO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Propound Pharma Consulting Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Propound Pharma Consulting Private Limited
Propound Pharma Consulting Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Propound Pharma Consulting Private Limited
Employment history and EPFO contributions of people linked to Propound Pharma Consulting.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Propound Pharma Consulting Private Limited
Propound Pharma Consulting Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Mokshagundam Pradeep ceased to be Additional Director on 07 Apr 2022.
Credit Ratings, Litigation & Regulatory Alerts for Propound Pharma Consulting Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Propound Pharma Consulting Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Propound Pharma Consulting Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Propound Pharma Consulting Private Limited
Propound Pharma Consulting has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Propound Pharma Consulting Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Propound Pharma Consulting Private Limited
Propound Pharma Consulting is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Propound Pharma Consulting is a company pending strike off, currently registered as a private limited company based in Bangalore, Karnataka, India. The company works in business and IT consulting, within the business outsourcing industry. It was incorporated on 29 June 2015 and is registered under CIN U24230KA2015PTC081212. The company may be struck off soon - caution is advised.
The compliance status of Propound Pharma Consulting is compliant as of 02 September 2026.
Propound Pharma Consulting has 2 current directors:
- Poornima Mokshagundam - Director
- Prathima Sundhar - Director
The CIN (Corporate Identification Number) of Propound Pharma Consulting is U24230KA2015PTC081212. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Propound Pharma Consulting was incorporated on 29 June 2015. It is registered with the Registrar of Companies, Bangalore.
Propound Pharma Consulting can be reached through the website propoundpharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Propound Pharma Consulting is at No 167 4th Main Road Judicial Layoutthalaghattapura, Bangalore, Karnataka, India – 560062.
Propound Pharma Consulting reported revenue of ₹12,480 for FY 2025 (down 100% YoY).
Propound Pharma Consulting has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh.
Propound Pharma Consulting reported a net loss of ₹3.53 Lakh and EBITDA of -₹3.53 Lakh for FY 2025, as per its filed financial statements.